LEDERMAN SETH 4
4 · Tonix Pharmaceuticals Holding Corp. · Filed Feb 24, 2023
Insider Transaction Report
Form 4
LEDERMAN SETH
DirectorChief Executive Officer
Transactions
- Award
Stock Option
2023-02-23+700,000→ 700,000 totalExercise: $0.91From: 2024-02-23Exp: 2033-02-23→ Common Stock (700,000 underlying) - Award
Stock Option
2023-02-23+700,000→ 700,000 totalExercise: $0.73From: 2024-02-23Exp: 2033-02-23→ Common Stock (700,000 underlying)
Footnotes (2)
- [F1]One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months.
- [F2]The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan.